BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Liver Foundation - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liverfoundation.org
X-WR-CALDESC:Events for American Liver Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T000000
DTEND;TZID=America/New_York:20250329T235959
DTSTAMP:20260420T205211
CREATED:20240805T211801Z
LAST-MODIFIED:20250327T163642Z
UID:10001298-1709251200-1743292799@liverfoundation.org
SUMMARY:Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
DESCRIPTION:We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25. \nUpon completion of this activity\, participants will: \n\nHave increased knowledge regarding the\n\nBiological rationale for using bispecific antibodies to target HER2 in GEA\n\n\nHave greater competence related to\n\nSelecting the most appropriate anti-HER2 therapy for a patient with HER2-positive GEA\nManaging adverse events associated with anti-HER2 therapies for patients with HER2-positive GEA\n\n\nDemonstrate greater confidence in their ability to\n\nCollaborate with the patient when developing a treatment plan for their HER2-positive GEA\n\n\n\nLearn more and register for this course: https://liver.fyi/HER2GEA \n 
URL:https://liver.fyi/HER2GEA#new_tab
LOCATION:On-Demand
CATEGORIES:Programs
ATTACH;FMTTYPE=image/png:https://liverfoundation.org/wp-content/uploads/2024/08/Fact-Sheet-What-Does-Your-Liver-Do.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T080000
DTEND;TZID=America/New_York:20241031T170000
DTSTAMP:20260420T205211
CREATED:20240702T155451Z
LAST-MODIFIED:20250723T200350Z
UID:10001057-1727769600-1730394000@liverfoundation.org
SUMMARY:Virtual Liver Life Walk
DESCRIPTION:
URL:https://liverlifewalk.org/virtualwalk#new_tab
LOCATION:Virtual
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2023/02/Liver-Life-Walk-640x360-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T120000
DTEND;TZID=America/New_York:20241001T130000
DTSTAMP:20260420T205211
CREATED:20240710T190528Z
LAST-MODIFIED:20241010T135130Z
UID:10001060-1727784000-1727787600@liverfoundation.org
SUMMARY:Liver Health ECHO Program - NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition
DESCRIPTION:Bringing Fatty Liver Disease Prevention & Treatment to Healthcare Providers on the Frontlines \n\n\n\nAmerican Liver Foundation created a new Project Echo program for healthcare providers that will bring treatment and prevention best practices for nonalcoholic fatty liver disease (NAFLD)*\, to non-liver experts. \n\n\n\nThe Liver Health ECHO Program is a virtual community of practice developed to equip healthcare providers with the necessary skills to treat and prevent NAFLD among their patients. Within this network\, participants will gain support and mentorship\, enhance their skills\, and connect with leaders in the field all at no cost. This program will provide\, \n\n\n\n\nStructured support in treating NAFLD with practical prevention strategies\n\n\n\nMentorship from peers and experts in the field\, collaborative problem-solving and sharing of resources\n\n\n\nConnection with other primary care providers and allied health professionals across the U.S.\n\n\n\n\nThe sessions will be held live via Zoom and will be recorded. There is no cost to participate. The sessions will be held monthly from 12:00 p.m. - 1:00 p.m. ET\, dates listed below: \n\n\n\n\nAugust 6\, 2024 - NAFLD 101: An Overview of the Condition\n\n\n\nSeptember 3\, 2024 - NAFLD Screening & Testing: Latest Advancements in Diagnostic Options\n\n\n\nOctober 1\, 2024 - NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition\n\n\n\nNovember 5\, 2024 - NAFLD Prevention: Utilizing Health Education to Improve Patient Health\n\n\n\nDecember 3\, 2024 - The Future of NAFLD: Emerging Issues & Resources\n\n\n\n\nThe October 1\, 2024 session titled NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition will be presented by Maya Balakrishnan\, MD\, MPH\, and Adam Buckholz\, MD\, MS.  \n\n\n\nRegister now! Click here: https://iecho.org/public/program/PRGM1717177145551LS098XFWSI \n\n\n\n*The nomenclature for nonalcoholic fatty liver disease (NAFLD) has recently changed to metabolic dysfunction associated steatotic liver disease (MASLD). Nonalcoholic steatohepatitis (NASH) has been renamed to metabolic dysfunction associated steatohepatitis (MASH). Fatty liver disease is now called steatotic liver disease. Learn more about the nomenclature changes in this video: https://liverfoundation.org/resource-center/videos/new-nomenclature-for-fatty-liver-disease/.
URL:https://liverfoundation.org/events/liver-health-echo-program-nafld-staging-treatment-how-to-effectively-treat-manage-each-stage-of-the-condition/
CATEGORIES:Programs
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2024/07/Project-Echo-Tile-1.jpg
END:VEVENT
END:VCALENDAR